Our Manufacturing and Supply Chain Network - Sanofi
Our award-winning site in Framingham, MA is among the world’s first digitally enabled facilities to use continuous-biologics-production technology. Its end-to-end platform uses millions of points of data captured by sensors to continuously optimize for excellence.
Sanofi - 690604 - 01/15/2025 | FDA
3 days ago · CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. Warning Letter 320-25-22. January 15, 2025. AMENDED (This letter replaces Warning Letter No. 320-25-22 dated December 16, 2024.)
Sanofi hit with FDA warning letter at Massachusetts drug …
3 days ago · Sanofi acquired Genzyme for a little over $20 billion back in 2011. Genzyme has historically focused its efforts on rare inherited disorders, kidney diseases, cancer, transplant and immune disease ...
Search Framingham Jobs at Sanofi
Hear from the ambitious, talented individuals who pull together to create better for patients.
FDA warns Sanofi of manufacturing irregularities at key facility
11 hours ago · Get Instant Summarized Text (Gist) The FDA has identified significant deviations from Current Good Manufacturing Practice at Sanofi's Genzyme plant in Framingham, Massachusetts.
Sanofi warned by FDA over 'significant' problems at a key ... - STAT
3 days ago · The FDA, whose inspectors visited the Framingham, Mass., plant in June and July 2024, also scolded Sanofi for “multiple” instances in which the facility deviated from so-called good ...
Working at Sanofi Framingham Office
Dubbed Sanofi at Cambridge Crossing, our new state-of-the-art facility will create an innovation hub promoting close collaboration and integration among business units. Join us and become part of a team dedicated to chasing the miracles of science that improve people’s lives.
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
THURSDAY, Jan. 23, 2025 -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts.
FDA cites contamination concerns in warning to Sanofi MA plant
2 days ago · In 2013, Sanofi invested $80 million to build a downstream facility at Framingham dedicated to Fabrazyme. Since then, Sanofi describes Framingham as "among the world’s first digitally enabled facilities to use continuous-biologics-production technology," in its literature. "Its end-to-end platform uses millions of points of data captured by ...
Sanofi Facility Draws FDA Scrutiny Over Alleged Quality Lapses - Sanofi …
2 days ago · The U.S. Food and Drug Administration (FDA) issued a warning letter to Sanofi SA’s SNY Genzyme Corporation regarding significant violations at its Framingham, Massachusetts, facility.. After an ...
- Some results have been removed